A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B. (Q43443038)
Jump to navigation
Jump to search
scientific article published on 7 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B. |
scientific article published on 7 August 2012 |
Statements
1 reference
A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B. (English)
1 reference
Ilaria Lenci
1 reference
Paola Piccolo
1 reference
Daniele di Paolo
1 reference
Luigi Demelia
1 reference
Orazio Sorbello
1 reference
Lorenzo Nosotti
1 reference
7 August 2012
1 reference
1 reference
Identifiers
1 reference